Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants
Patricia M. Flynn(St. Jude Children's Research Hospital), Arlene Bardeguez(University Hospital, Newark), Patrick Jean‐Philippe(Jackson Foundation), Jack Rodman(Boston University), Sharon Huang(FuelCell Energy (United States)), Murli Purswani, James F. Rooney(Gilead Sciences (United States)), David E. Shapiro(Intercept Pharmaceuticals (United States)), D. Heather Watts(National Institutes of Health), Amanda Cotter(Bronx-Lebanon Hospital Center), Brian L. Robbins(University of North Carolina at Chapel Hill), Koen K. A. Van Rompay(University of California, Davis), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Barbara Heckman(Frontier Science & Technology Research Foundation, Inc.), Mark Mirochnick(Boston University), Susan A. Fiscus(University of North Carolina at Chapel Hill), Brian P. Kearney(Belfast Health and Social Care Trust), Edwin Thorpe(University of Tennessee Health Science Center)
Cited by 57
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k